{"id":"W2129834424","doi":"10.1182/blood-2005-06-2317","title":"131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; Cancer Research Society","keywords":"Busulfan; Medicine; Cyclophosphamide; Myeloid leukemia; Transplantation; Myeloid; Bone marrow; Total body irradiation; Internal medicine; Leukemia; Gastroenterology; Hazard ratio; Haematopoiesis; Hematopoietic stem cell transplantation; Immunology; Surgery; Oncology; Chemotherapy; Stem cell; Biology; Confidence interval","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018353,0.0002878074,0.000645872,0.0002319109,0.0001024184,0.0000140152,0.0001173513,0.0002218418,0.00002841697],"category_scores_gemma":[0.00002018439,0.0002357849,0.0001350144,0.0002612715,0.00009474724,0.0001005543,0.00002513704,0.0001143311,0.000008295979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006832387,"about_ca_system_score_gemma":0.0005285504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002118243,"about_ca_topic_score_gemma":0.0001515051,"domain_scores_codex":[0.998198,0.00003155748,0.0005283619,0.0004657151,0.0003054285,0.0004709072],"domain_scores_gemma":[0.9991132,0.0001075977,0.0001312917,0.0003483148,0.00008440253,0.0002151666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003642669,0.002027464,0.1808845,0.003257036,0.0006803207,0.0008664045,0.01062478,0.0004077063,0.7840568,0.00009674645,0.0002045489,0.01325096],"study_design_scores_gemma":[0.04068329,0.002526564,0.2154962,0.000548705,0.001427902,0.0007205802,0.0002461596,0.00191614,0.7332947,0.00005537573,0.002701438,0.0003828563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956601,0.001437471,0.0002296279,0.0007060347,0.00003189058,0.001432802,0.00008510382,0.00004376139,0.0003731925],"genre_scores_gemma":[0.9865952,0.008142422,0.003677672,0.00006013457,0.0001304409,0.00008611178,0.0003787107,0.00005602547,0.0008733289],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05076212,"threshold_uncertainty_score":0.9615028,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01081085101877537,"score_gpt":0.2814298008304982,"score_spread":0.2706189498117228,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}